1997
DOI: 10.1002/stem.150190
|View full text |Cite
|
Sign up to set email alerts
|

TGF‐β Latency: Biological Significance and Mechanisms of Activation

Abstract: Transforming growth factor (TGF-)β is secreted as a latent complex in which the mature growth factor remains associated with its propeptide. In order to elicit a biological response, the cytokine must be released from the latent complex, a process termed latent TGF-β activation or TGF-β formation. Although latent TGF-β activation is a critical step in the regulation of its activity, little is known about the molecular mechanisms that lead to the production of active TGF-β. In this article, we present an overvi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

2
193
0
7

Year Published

1998
1998
2010
2010

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 240 publications
(202 citation statements)
references
References 73 publications
2
193
0
7
Order By: Relevance
“…Transforming growth factor-b is generally released from cells in a latent, biologically inactive form (Miyazono et al, 1993). Following release, it is activated by a variety of mechanisms, including exposure to proteolytic enzymes or alkaline pH conditions (Gleizes et al, 1997;Khalil, 1999). The presence of proteases in the pancreas and the alkaline pH of pancreatic juice may result in ideal conditions for activation of latent TGF-b.…”
Section: Discussionmentioning
confidence: 99%
“…Transforming growth factor-b is generally released from cells in a latent, biologically inactive form (Miyazono et al, 1993). Following release, it is activated by a variety of mechanisms, including exposure to proteolytic enzymes or alkaline pH conditions (Gleizes et al, 1997;Khalil, 1999). The presence of proteases in the pancreas and the alkaline pH of pancreatic juice may result in ideal conditions for activation of latent TGF-b.…”
Section: Discussionmentioning
confidence: 99%
“…One possible explanation for this finding is that the processing of TGF-␤1 from its inactive precursor may be limiting (McDowell et al, 2001). Processing of TGF-␤ superfamily members is complex but clearly very important (Gleizes et al, 1997). They are synthesized as zymogen-like pre-proteins whose carboxyl-terminal one third is the actual ligand, whereas the amino-terminal two thirds is a "latency peptide" or "pro-domain."…”
Section: Establishment Of Morphogen Gradients Part I: Evidence For Dmentioning
confidence: 99%
“…16 TGF-b 1 is produced in a latent complex, which consists of TGF-b 1 noncovalently bound to a latentassociated peptide (LAP). 17 It is the removal of the LAP, which allows TGF-b 1 to be biologically active. This activation step is a major controlling point in the regulation of TGF-b 1 biological activity, but the mechanisms controlling TGF-b 1 activation are only partially understood.…”
mentioning
confidence: 99%
“…This activation step is a major controlling point in the regulation of TGF-b 1 biological activity, but the mechanisms controlling TGF-b 1 activation are only partially understood. Several activation mechanisms have been shown, including proteolytic and enzymatic processes, 17 as well as integrin binding. 18,19 Some earlier work provided evidence that ROS could play a role in activating TGF-b.…”
mentioning
confidence: 99%